UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 672

Sortiert nach

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (9), p.E966-E972

2015

Volltextzugriff (PDF)

vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (36), p.14526-14531

2012

Volltextzugriff (PDF)

Cell-free production of Gaussia princeps luciferase – antibody fragment bioconjugates for ex vivo detection of tumor cells

Biochemical and biophysical research communications, 2009-12, Vol.390 (3), p.971-976

2009

Volltextzugriff (PDF)

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Blood, 2006-10, Vol.108 (8), p.2745-2754

2006

Volltextzugriff (PDF)

Conjugation of an anti–transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells

Molecular cancer therapeutics, 2007-11, Vol.6 (11), p.2995-3008

2007

Volltextzugriff (PDF)

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)–infected patients rarely react with the viral proteins

Blood, 2014-03, Vol.123 (10), p.1512-1515

2014

Volltextzugriff (PDF)

An Anti-Transferrin Receptor-Avidin Fusion Protein Exhibits Both Strong Proapoptotic Activity and the Ability to Deliver Various Molecules into Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 2002-08, Vol.99 (16), p.10706-10711

2002

Volltextzugriff (PDF)

The use of multiple displacement amplification to amplify complex DNA libraries

Nucleic acids research, 2008-03, Vol.36 (5), p.e32

2008

Volltextzugriff (PDF)

Escherichia coli-based production of a tumor idiotype antibody fragment – tetanus toxin fragment C fusion protein vaccine for B cell lymphoma

Protein expression and purification, 2011, Vol.75 (1), p.15-20

2011

Volltextzugriff (PDF)

Transforming into the new era: public relations industry in Hong Kong and China

Public relations review, 2013-12, Vol.39 (5), p.575-577

2013

Volltextzugriff (PDF)

Role of Language and Corporate Communication in Greater China: From Academic to Practitioner Perspectives

2015, 2015

Volltextzugriff (PDF)

Genome-wide expression changes induced by HTLV-1 tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation

Oncogene, 2001-07, Vol.20 (33), p.4484-4496

2001

Volltextzugriff (PDF)

Efficient and Rapid Affinity Purification of Proteins Using Recombinant Fusion Proteases

Bio/technology (New York, N.Y. 1983), 1994-06, Vol.12 (6), p.601-605

1994

Volltextzugriff (PDF)

The Effects of BCMA Expression, Soluble BCMA, and Combination Therapeutics on the Anti-Tumor Activity of HPN217, a BCMA-Targeting Tri-Specific T Cell Engager Against Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.1185-1185

2021

Volltextzugriff (PDF)

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Volltextzugriff (PDF)

Updated Interim Results from a Phase 1 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC®) Targeting B Cell Maturation Antigen (BCMA) for Relapsed/Refractory Multiple Myeloma (RRMM)

Blood, 2022-11, Vol.140 (Supplement 1), p.7284-7285

2022

Volltextzugriff (PDF)

Abstract 5081: Anti-tumor activity of HPN217, a BCMA-targeting tri-specific T cell engager, is enhanced by γ-secretase inhibitors in preclinical models

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5081-5081

2023

Volltextzugriff (PDF)

Preliminary Clinical Data from a Phase 1 Trial with CPI-818, a Selective ITK Inhibitor That Preferentially Blocks the Growth of T Lymphoma Cells

Blood, 2019-11, Vol.134 (Supplement_1), p.1571-1571

2019

Volltextzugriff (PDF)

Abstract 1313: CPI-818: A selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1313-1313

2019

Volltextzugriff (PDF)

Vaccination with novel combinations of anti-HER2/ neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/ neu expressing tumors

Vaccine, 2006-01, Vol.24 (3), p.304-316

2006

Volltextzugriff (PDF)

Ibrutinib Enhances the Activity of Anti-CD20 Antibodies in an MCL Mouse Model: Effect of Drug at Clinically Relevant Concentrations on ADCC and ADCP

Blood, 2015-12, Vol.126 (23), p.3998-3998

2015

Volltextzugriff (PDF)

Dominant Wilty Mutants of Zea mays (Poaceae) Are not Impaired in Abscisic Acid Perception or Metabolism

American journal of botany, 1999-12, Vol.86 (12), p.1796-1800

1999

Volltextzugriff (PDF)

Dominant Wilty mutants of Zea mays (Poaceae) are not impaired in abscisic acidperception or metabolism

American journal of botany, 1999-12, Vol.86 (12), p.1796-1800

1999

Volltextzugriff (PDF)

Targeting B-Cell Lymphoma with Idiotype-Specific Peptibodies: Toward a Personalized and Tumor-Specific Therapy

Blood, 2012-11, Vol.120 (21), p.3713-3713

2012

Volltextzugriff (PDF)

Novel Anti-CD19/Idiotype Bispecific Diabody Vaccine for B-Cell Lymphoma

Blood, 2009-11, Vol.114 (22), p.2712-2712

2009

Volltextzugriff (PDF)

1 – 25 von 672

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(584)
Mit Volltextzugriff
(601)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(509)
Life Sciences & Biomedicine
(404)
Humans
(346)
Female
(199)
Male
(188)
Biological And Medical Sciences
(131)
Middle Aged
(129)
Animals
(111)
Adult
(105)
Aged
(97)
Medical Sciences
(95)
Cardiovascular System & Cardiology
(72)
Cardiac & Cardiovascular Systems
(67)
Surgery
(57)
Technology
(57)
Mice
(56)
Biochemistry & Molecular Biology
(50)
Fundamental And Applied Biological Sciences. Psychology
(50)
Risk Factors
(44)
Adolescent
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity

Cell-free production of Gaussia princeps luciferase – antibody fragment bioconjugates for ex vivo detection of tumor cells

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Conjugation of an anti–transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)–infected patients rarely react with the viral proteins

An Anti-Transferrin Receptor-Avidin Fusion Protein Exhibits Both Strong Proapoptotic Activity and the Ability to Deliver Various Molecules into Cancer Cells

The use of multiple displacement amplification to amplify complex DNA libraries

Escherichia coli-based production of a tumor idiotype antibody fragment – tetanus toxin fragment C fusion protein vaccine for B cell lymphoma

Transforming into the new era: public relations industry in Hong Kong and China

Role of Language and Corporate Communication in Greater China: From Academic to Practitioner Perspectives

Genome-wide expression changes induced by HTLV-1 tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation

Efficient and Rapid Affinity Purification of Proteins Using Recombinant Fusion Proteases

The Effects of BCMA Expression, Soluble BCMA, and Combination Therapeutics on the Anti-Tumor Activity of HPN217, a BCMA-Targeting Tri-Specific T Cell Engager Against Multiple Myeloma

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

Updated Interim Results from a Phase 1 Study of HPN217, a Half-Life Extended Tri-Specific T Cell Activating Construct (TriTAC®) Targeting B Cell Maturation Antigen (BCMA) for Relapsed/Refractory Multiple Myeloma (RRMM)

Abstract 5081: Anti-tumor activity of HPN217, a BCMA-targeting tri-specific T cell engager, is enhanced by γ-secretase inhibitors in preclinical models

Preliminary Clinical Data from a Phase 1 Trial with CPI-818, a Selective ITK Inhibitor That Preferentially Blocks the Growth of T Lymphoma Cells

Abstract 1313: CPI-818: A selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas

Vaccination with novel combinations of anti-HER2/ neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/ neu expressing tumors

Ibrutinib Enhances the Activity of Anti-CD20 Antibodies in an MCL Mouse Model: Effect of Drug at Clinically Relevant Concentrations on ADCC and ADCP

Dominant Wilty Mutants of Zea mays (Poaceae) Are not Impaired in Abscisic Acid Perception or Metabolism

Dominant Wilty mutants of Zea mays (Poaceae) are not impaired in abscisic acidperception or metabolism

Targeting B-Cell Lymphoma with Idiotype-Specific Peptibodies: Toward a Personalized and Tumor-Specific Therapy

Novel Anti-CD19/Idiotype Bispecific Diabody Vaccine for B-Cell Lymphoma

Suchergebnisse filtern